These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 27842816)
1. Dimethyl-β-cyclodextrin/salazosulfapyridine inclusion complex-loaded chitosan nanoparticles for sustained release. Tang P; Yang H; Tang B; Wu D; Du Q; Xu K; Li H Carbohydr Polym; 2017 Jan; 156():215-222. PubMed ID: 27842816 [TBL] [Abstract][Full Text] [Related]
2. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes. Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666 [TBL] [Abstract][Full Text] [Related]
3. Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity. Tang P; Sun Q; Zhao L; Pu H; Yang H; Zhang S; Gan R; Gan N; Li H Carbohydr Polym; 2018 Oct; 198():418-425. PubMed ID: 30093018 [TBL] [Abstract][Full Text] [Related]
4. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release. Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276 [TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery. Zhang P; Liu X; Hu W; Bai Y; Zhang L Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746 [TBL] [Abstract][Full Text] [Related]
6. Effect of hydroxypropyl-β-cyclodextrin on the bounding of salazosulfapyridine to human serum albumin. Tang P; Tang B; Wang Q; Xu K; Xiong X; Li H Int J Biol Macromol; 2016 Nov; 92():105-115. PubMed ID: 27418290 [TBL] [Abstract][Full Text] [Related]
7. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles. Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293 [TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery. Khalil SK; El-Feky GS; El-Banna ST; Khalil WA Carbohydr Polym; 2012 Oct; 90(3):1244-53. PubMed ID: 22939337 [TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and in vitro release study of β-cyclodextrin/chitosan nanoparticles loaded Cinnamomum zeylanicum essential oil. Matshetshe KI; Parani S; Manki SM; Oluwafemi OS Int J Biol Macromol; 2018 Oct; 118(Pt A):676-682. PubMed ID: 29959997 [TBL] [Abstract][Full Text] [Related]
10. pH and temperature stability of (-)-epigallocatechin-3-gallate-β-cyclodextrin inclusion complex-loaded chitosan nanoparticles. Liu F; Majeed H; Antoniou J; Li Y; Ma Y; Yokoyama W; Ma J; Zhong F Carbohydr Polym; 2016 Sep; 149():340-7. PubMed ID: 27261758 [TBL] [Abstract][Full Text] [Related]
11. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol. Deng F; Hu W; Chen H; Tang Y; Zhang L Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869 [TBL] [Abstract][Full Text] [Related]
12. Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Ibrutinib Delivery: A Potential Nanoformulation of Novel Kinase Inhibitor. Zhao L; Tang B; Tang P; Sun Q; Suo Z; Zhang M; Gan N; Yang H; Li H J Pharm Sci; 2020 Feb; 109(2):1136-1144. PubMed ID: 31606544 [TBL] [Abstract][Full Text] [Related]
13. A study on the preparation of chitosan-tripolyphosphate nanoparticles and its entrapment mechanism for egg white derived peptides. Du Z; Liu J; Zhang T; Yu Y; Zhang Y; Zhai J; Huang H; Wei S; Ding L; Liu B Food Chem; 2019 Jul; 286():530-536. PubMed ID: 30827643 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of β-cyclodextrin modified chitosan-poly(acrylic acid) nanoparticles and use as drug carriers. Wang X; Chen C; Huo D; Qian H; Ding Y; Hu Y; Jiang X Carbohydr Polym; 2012 Sep; 90(1):361-9. PubMed ID: 24751053 [TBL] [Abstract][Full Text] [Related]
15. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies. Rastegari B; Karbalaei-Heidari HR; Zeinali S; Sheardown H Colloids Surf B Biointerfaces; 2017 Oct; 158():589-601. PubMed ID: 28750341 [TBL] [Abstract][Full Text] [Related]
16. Targeted drug delivery of Sunitinib Malate to tumor blood vessels by cRGD-chiotosan-gold nanoparticles. Saber MM; Bahrainian S; Dinarvand R; Atyabi F Int J Pharm; 2017 Jan; 517(1-2):269-278. PubMed ID: 27956189 [TBL] [Abstract][Full Text] [Related]
18. Sensitive complex micelles based on host-guest recognition from chitosan-graft-β-cyclodextrin for drug release. Gao Y; Li G; Zhou Z; Gao L; Tao Q Int J Biol Macromol; 2017 Dec; 105(Pt 1):74-80. PubMed ID: 28673842 [TBL] [Abstract][Full Text] [Related]
19. Exploring oral drug delivery: In vitro release and mathematical modeling of hydrophobic drug (Na-L-thyroxine) and its cyclodextrin inclusion complex in chitosan microparticles. Lakkakula J; Krause RWM; Barage S; Joshi A; Patil S; Khan AA; Roy A Int J Biol Macromol; 2024 Apr; 265(Pt 2):131019. PubMed ID: 38513906 [TBL] [Abstract][Full Text] [Related]
20. Sulfobutylether-β-cyclodextrin/chitosan nano- and microparticles and their physicochemical characteristics. Fülöp Z; Saokham P; Loftsson T Int J Pharm; 2014 Sep; 472(1-2):282-7. PubMed ID: 24971695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]